Oral semaglutide is generally considered for individuals with a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 or higher when accompanied by weight-related health concerns
Creating a tight vacuum seal to help prevent air ingress and spillage when drawing to maximum barrel capacity or during administration
In these cases, discuss dose reduction or slower escalation with your healthcare provider
The FDA has approved these weight management agents for adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia
Proper organization of your supplies is key to a smooth injection process
Virili C, Fallahi P, Antonelli A, Benvenga S, Centanni M